Cargando…
YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6
BACKGROUND: Tumor-associated macrophages are mainly polarized into the M2 phenotype, remodeling the tumor microenvironment and promoting tumor progression by secreting various cytokines. METHODS: Tissue microarray consisting of prostate cancer (PCa), normal prostate, and lymph node metastatic sample...
Autores principales: | Chen, Saisai, Lu, Kai, Hou, Yue, You, Zonghao, Shu, Chuanjun, Wei, Xiaoying, Wu, Tiange, Shi, Naipeng, Zhang, Guangyuan, Wu, Jianping, Chen, Shuqiu, Zhang, Lihua, Li, Wenchao, Zhang, Dingxiao, Ju, Shenghong, Chen, Ming, Xu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152059/ https://www.ncbi.nlm.nih.gov/pubmed/37094986 http://dx.doi.org/10.1136/jitc-2022-006020 |
Ejemplares similares
-
Upregulation of miR-146a by YY1 depletion correlates with delayed progression of prostate cancer
por: Huang, Yeqing, et al.
Publicado: (2017) -
IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2020) -
IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma
por: Weber, Rebekka, et al.
Publicado: (2020) -
Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer
por: Sima, Livia Elena, et al.
Publicado: (2021) -
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors
por: Beyranvand Nejad, Elham, et al.
Publicado: (2021)